Last reviewed · How we verify

60% of oxygen concentration.

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · FDA-approved active Small molecule Quality 5/100

60% of oxygen concentration. is a Small molecule drug developed by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau. It is currently FDA-approved.

At a glance

Generic name60% of oxygen concentration.
SponsorFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about 60% of oxygen concentration.

What is 60% of oxygen concentration.?

60% of oxygen concentration. is a Small molecule drug developed by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau.

Who makes 60% of oxygen concentration.?

60% of oxygen concentration. is developed and marketed by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (see full Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau pipeline at /company/fundaci-institut-de-recerca-de-l-hospital-de-la-santa-creu-i-sant-pau).

What development phase is 60% of oxygen concentration. in?

60% of oxygen concentration. is FDA-approved (marketed).

Related